Pharmaceutical Business review

NextBio Signs License Agreement With UCB

NextBio Enterprise offers life sciences organisations tools for knowledge discovery and collaboration, seamless integration of internal and external research data, and secure data access.

Saeid Akhtari, co-founder and CEO of NextBio, said: “UCB is one of the biopharmaceutical companies, with operations in Europe, the US and Asia. We are very pleased that they are adopting the Enterprise version of the NextBio platform as an integral part of their research and development efforts.

“UCB’s adoption of NextBio Enterprise will enable its scientists to gain unique insights from data created by diverse high-throughput technologies.”